The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2020 | ADAURA clinical trial update
Deborah Doroshow
• 23 Sep 2020
Deborah Doroshow, MD, PhD, Mount Sinai Medical Center, New York, NY, discusses results from the ADAURA (NCT02511106) clinical trial, which demonstrated a significant decrease in brain metastases with adjuvant osimertinib versus a placebo. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
